No Detail Found!

In silico identification and characterization of potent laccase inhibitors against Cryptococcus neoformans: A multi-scale computational study

Author(s)
Muharib Alruwaili Centre for Immunology and Infection (C2i), Hong Kong Science and Technology Park,,Hong Kong, SAR China
Sonia Younas Centre for Immunology and Infection (C2i), Hong Kong Science and Technology Park, Hong Kong, SAR China; HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Muhammad Umer Khan Institute of Molecular Biology and Biotechnology, The University of Lahore,Lahore, 54590,Pakistan
Hammad Saleem Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences (UVAS),Lahore,Pakistan
Yasir Alruwaili Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia; Sustainable Development Research and Innovation Center, Deanship of Graduate Studies and Scientific Research, Jouf University, Sakaka 72388, Saudi Arabia
Abualgasim Elgaili Abdalla Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University,Sakaka 72388,Saudi Arabia
Bi Bi Zainab Mazhari Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University,Qurayyat 75911,Saudi Arabia
Khalid Abosalif Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University,Sakaka 72388,Saudi Arabia
Hasan Ejaz Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University,Sakaka 72388,Saudi Arabia
Abstract
Cryptococcus neoformans is an opportunistic fungal pathogen, especially affecting individuals with weakened immune systems. Laccase enzymes are pivotal in its pathogenicity, making them promising targets for therapeutic intervention. This study aims to identify and characterize potent laccase inhibitors against C. neoformans using advanced in-silico analysis. The laccase protein (UniProt ID: Q55P57) was retrieved via AlphaFold and validated with ProCheck. Pharmacophore-based virtual screening (PBVS) identified 19 potential inhibitors, which were docked using CB-Dock2. The top six compound's pharmacokinetic properties were assessed using SwissADME, PKCSM, and StopTox. Bioactivity was predicted via SwissTargetPrediction. Density Functional Theory (DFT) calculations were conducted using Gauss view 5.0.8. The validated 3D structure of the target protein Q55P57 demonstrated high quality, with 86.5% of residues in favored regions. The molecular docking revealed that L-11 exhibited the highest binding affinity (-13.2 kcal/mol), forming crucial interactions within the active site. L-11 displayed favorable physicochemical properties, including high lipophilicity and good Caco2 permeability, positioning it as a strong candidate for therapeutic development. Toxicity predictions indicated non-toxicity for acute inhalation and oral exposure, while bioactivity analysis highlighted its broad target interactions. DFT analysis demonstrated L-11's enhanced reactivity due to its high dipole moment and low HOMO-LUMO energy gap. The identification of L-11 (8-[4-[9,9-Dimethyl-7-(2,3,4,5,6,7,8,9,10-nonahydroxypyren-1-yl)fluoren-2yl]phenyl]pyrene-1,2,3,4,5,6,7,9,10-nonol) as a potent inhibitor of C. neoformans laccase represents a novel approach to antifungal drug discovery, marking a significant step to combat fungal infections and a way forward to perform in-vitro and in-vivo studies and ultimately its clinical application.
Publication Details
Page(s) 1-24
Published Journal: Asian Journal of Agriculture and Biology, Volume: 3, Issue: 0, Year: 2025

Request the full text from PASTIC

Keywords
ADMET, neoformans, Antifungal, C, molecular docking, Ellagic acid, Laccase inhibitor
References
Andriani GM,Spoladori LFdA,Fabris M,Camargo PG,Pereira PML,Santos JP,BartolomeuGonçalves G,Alonso L,Lancheros CAC,Alonso A,Nakamura CV,Macedo FJ,PingeFilho P,Yamauchi LM,Bispo MdLF,Tavares ER,Yamada-Ogatta SF .2023 .Synergistic antifungal interaction of N(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans. Front. Microbiol, 1040671 : .
Ayaz M,Ullah FSA,Ullah FOM,Ahmed J,Devkota HP .2019 .Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. Chem. Biol. Interact, 308 : 294-303.
.2019 .. , 05 : .
Azam F,Khan MA,Khan A,Ahmad S,Zofair SFF,Younus H .2022 .In silico and in vitro studies on the inhibition of laccase activity by Ellagic acid: Implications in drug designing for the treatment of Cryptococcal infections. Int. J. Biol. Macromol, 04 : 642-654.
Bastos RW,Rossato L,Goldman GH,Santos DA .2021 .Fungicide effects on human fungal pathogens: cross-resistance to medical drugs and beyond. PLoS Pathog, 1010073(12) : 1010073.
Borba JVB,Alves VM,Braga RC,Korn DR,Overdahl K,Silva AC,Hall SUS,Overdahl E,Kleinstreuer N,Strickland J,Allen D,Andrade CH,Muratov EN,Tropsha A .2022 .STopTox: An in silico alternative to animal testing for acute systemic and topical toxicity. Environ. Health Perspect, 130(2) : 27012.
Cao Y,Song L,Miao Z,Hu Y,Tian L,Jiang T .2011 .Improved side-chain modeling by coupling clash-detection guided iterative search with rotamer relaxation. Bioinformatics, 27(6) : 785-790.
Chen J,Shao J,Dai M,Fang W,Yang YL .2023 .Adaptive immunology of Cryptococcus neoformans infections-an update. Front. Immunol, 14 : .
Chitty JL,Blake KL,Blundell RD,Koh YQAE,Thompson M,Robertson AAB,Butler MS,Cooper MA,Kappler U,Williams SJ,Kobe B,Fraser JA .2017 .Cryptococcus neoformans ADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design. J. Biol. Chem, 292(28) : 11829-11839.
Yeates Colovos C,TO Colovos C .1993 .Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci, 2(9) : 1511-1519.
Daina A,Zoete V .2024 .Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning. Commun. Chem, 7(1) : 105.
Datta A,Yadav V,Ghosh A,Choi J,Bhattacharyya D,Kar RK,Ilyas H,Dutta A,An E,Mukhopadhyay J,Lee D,Sanyal K,Ramamoorthy A,Bhunia A .2016 .Mode of action of a designed antimicrobial peptide: high potency against Cryptococcus neoformans. Biophys J, 08(8) : 1724-1737.
Eberhardt J,Santos-Martins D,Tillack AF,Forli S .2021 .New docking methods, expanded force field, and python bindings. JCIM, 61(8) : 3891-3898.
Fisher MC,Alastruey-Izquierdo A,Berman J,Bicanic T,Bignell EM,Bowyer P,Bromley M,Brüggemann R,Garber G,Cornely OA,Gurr SJ,Harrison TS,Kuijper E,Rhodes J,Sheppard DC,Warris A,White PL,Xu J,Zwaan B,Verweij PE .2022 .Tackling the emerging threat of antifungal resistance to human health. Nat. Rev. Microbiol, 20(9) : 557-571.
Garrido A,Lepailleur A,Mignani SM,Dallemagne P,Rochais C .2020 .hERG toxicity assessment: Useful guidelines for drug design. Eur. J. Med. Chem, 11229 : 0.
Ghannoum MA,Rice LB .1999 .Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev, 12(4) : 501-517.
Guth BD,Rast G .2009 .Dealing with hERG liabilities early: diverse approaches to an important goal in drug development. Br. J. Pharmacol, 00265(1) : 5381-24.
Gutierrez-Gongora D,Geddes-McAlister J .2022 .Peptidases: promising antifungal targets of the human fungal pathogen, Cryptococcus neoformans. Facets, 7(1) : 319-342.
Huang YS,Liu CE,Lin SP,Lee CH,Yang CJ,Lin CY,Tang HJ,Lee YC,Lin YC,Lee YT,Sun HY,Hung CC .2019 .Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia. AIDS, 33(8) : 000000000000-2207.
Illicachi LA,Montalvo-Acosta JJ,Insuasty A,Quiroga J,Abonia R,Sortino M,Zacchino S,Insuasty B,-dihydro- B .2017 .-carbaldehyde derivatives as antifungal agents. Molecules, 22(9) : 1476.
Islam S,Hussain EA,Shujaat S,Khan MU,Ali Q,Malook SU,Ali D .2024 .Antibacterial potential of Propolis: molecular docking, simulation and toxicity analysis. AMB Express, 14(1) : 81.
Khan MA,Khan A,Azam M,Allemailem KS,Alrumaihi F,Almatroudi A,A Alhumaydhi F,Azam F,Khan SH,Zofair SFF,Ahmad S,Younus H .2021 .Liposomal ellagic acid alleviates cyclophosphamide-induced toxicity and eliminates the systemic Cryptococcus neoformans infection in leukopenic mice. Pharmaceutics, 13(6) : 882.
Khan MF,Ali A,Rehman HM,Noor Khan S,Hammad HM,Waseem M,Wu Y,Clark TG,Jabbar A .2024 .Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis. Sci. Rep, 14(1) : 10904.
Khan MU,Sakhawat A,Rehman R,Wali AH,Ghani MU,Akram A,Javed MA,Ali Q,Yu-Ming Z,Ali D .2024 .Identification of novel natural compounds against CFTR p. Gly628Arg pathogenic variant. AMB Express, 14(1) : 99.
Langeveld WT,Veldhuizen EJA,Burt SA .2013 .Synergy between essential oil components and antibiotics: a review. Crit. Rev. Microbiol, 7632(1) : 76-94.
Laniado-Laborín R,Cabrales-Vargas MN .2009 .side effects and toxicity Revista iberoamericana de micologia. , 26(4) : 223-227.
.2009 .. , 06 : .
Laskowski RA,Rullmannn JA,MacArthur MW,Kaptein R,Thornton JM .1996 .AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR, 8(4) : 477-486.
Liu Y,Yang X,Gan J,Chen S,Xiao ZX,Cao Y .2022 .improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res, 50(W1) : W159-W164.
Maniak H,Talma M,Giurg M .2021 .Inhibitory potential of new phenolic hydrazidehydrazones with a decoy substrate fragment towards laccase from a phytopathogenic fungus: SAR and molecular docking studies. Int. J. Mol. Sci, 22(22) : 12307.
Mehra R,Muschiol J,Meyer AS,Kepp KP .2018 .A structural-chemical explanation of fungal laccase activity. Sci. Rep, 8(1) : 17285.
Molloy SF,Kanyama C,Heyderman RS,Loyse A,Kouanfack C,Chanda D,Mfinanga S,Temfack E,Lakhi S,Lesikari S,Chan AK,Stone N,Kalata N,Karunaharan N,Gaskell K,Peirse M,Ellis J,Chawinga C,Lontsi S,Ndong JG,Bright P,Lupiya D,Chen T,Bradley J,Adams J,van der Horst C,Oosterhout JJ,Sini V,Mapoure YN,Mwaba P,Bicanic T,Lalloo DG,Wang D,Hosseinipour MC,Lortholary O,Jaffar S,Harrison TS .2018 .Antifungal combinations for treatment of cryptococcal meningitis in Africa. N. Engl. J. Med, 378(11) : 1004-1017.
Moreira-Walsh B,Ragsdale A,Lam W,Upadhya R,Xu E,Lodge JK,Donlin MJ .2022 .Membrane integrity contributes to resistance of cryptococcus neoformans to the cell wall inhibitor caspofungin. mSphere. 7, (4) : e0013422.
. .. , : 22.
Norhayati EJ,Diyah NW,Tejo BA,Ahmed S .2023 .Chemoinformatics approach to design and develop vanillin analogs as COX-1 inhibitor. , 14(Suppl 1) : 2517.
.2023 .. , 2517 : .
.2022 .WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization (WHO), : .
Orio M,Pantazis DA,Neese F .2009 .Density functional theory. Photosynth. Res, 102(2-3) : 443-453.
Truhlar Peverati R,DG Peverati R .2011 .Quest for a universal density functional: the accuracy of density functionals across a broad spectrum of databases in chemistry and physics. Philos. Trans. A Math. Phys. Eng. Sci, 372 : 20120476.
.2012 .. , 0476 : .
Pires DEV,Blundell TL,Ascher DB .2015 .predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem, 58(9) : 4066-4072.
Qadri H,Shah AH,Mir M .2021 .Novel strategies to combat the emerging drug resistance in human pathogenic microbes. Curr. Drug Targets, 22(12) : 1424-1436.
Ríos JL,Giner RM,Marín M,Recio MC .2018 .A pharmacological update of ellagic acid. Planta Med, 84(15) : 1068-1093.
Sakhawat A,Awan SJ,Khan MU,Shahid S,Maqbool T,Zubair HM,Manzoor H,Khan S .2024 .In silico and in vitro analyses to investigate the effects of vitamin C on VEGF protein. J. Taibah Univ. Med. Sci, 06(4) : 775-789.
Sakhawat A,Khan MU,Rehman R,Khan S,Shan MA,Batool A,Javed MA,Ali Q .2023 .Natural compound targeting BDNF V66M variant: insights from in silico docking and molecular analysis. AMB Express, 13(1) : 134.
Sarkar S,Siddiqui AA,Mazumder S,De R,Saha SJ,Banerjee C,Iqbal MS,Adhikari S,Alam A,Roy S,Bandyopadhyay U .2015 .Ellagic Acid, a dietary polyphenol, inhibits tautomerase activity of human macrophage migration inhibitory factor and its proinflammatory responses in human peripheral blood mononuclear cells. J. Agric. Food Chem, 63(20) : 4988-4998.
Singh S,Fatima Z,Hameed S .2015 .Predisposing factors endorsing Candida infections. Infez. Med, 23(3) : 211-223.
Sulistyowaty MI,Putra GS,Budiati T,Indrianingsih AW,Anwari F,Kesuma D,Matsunami K,Yamauchi T .2023 .. Antibacterial and Antifungal Activities of Nphenylbenzamides. Int. J. Mol. Sci, 24(3) : 2745.
Koes Sunseri J,DR Sunseri J .2016 .Pharmit: interactive exploration of chemical space. Nucleic Acids Res, 44(W1) : W442-W448.
Varadi M,Bertoni D,Magana P,Paramval U,Pidruchna I,Radhakrishnan M,Tsenkov M,Nair S,Mirdita M,Yeo J,Kovalevskiy O,Tunyasuvunakool K,Laydon A,Žídek A,Tomlinson H,Hariharan D,Abrahamson J,Green T,Jumper J,Birney E,Steinegger M,Hassabis D,Velankar S .2024 .AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res, 52(D1) : D368-D375.
Vinardell MP,Mitjans M .2008 .Alternative methods for eye and skin irritation tests: an overview. J. Pharm. Sci, 97(1) : 46-59.
Yang X,Liu Y,Gan J,Xiao ZX,Cao Y .2022 .FitDock: protein-ligand docking by template fitting. Brief. Bioinform, 23(3) : .
Zhao Y,Ye L,Zhao F,Zhang L,Lu Z,Chu T,Wang S,Liu Z,Sun Y,Chen M,Liao G,Ding C,Xu Y,Liao W,Wang L .2023 .Cryptococcus neoformans, a global threat to human health. Infect. Dis. Poverty, 12(1) : 20.
Zhu X,Gibbons J,Garcia-Rivera J,Casadevall A,Williamson PR A .2001 .Laccase of Cryptococcus neoformans is a cell wallassociated virulence factor. Infect. Immun, 69(9) : 5589-5596.
0

Citations

0

Downloads

12

Views